Eye Treatments News
Regenera Keeps Its Eye On The Prize
Friday September 3, 2004
Eye disease specialist Regenera expects to announce its first commercial licensing agreement within 60 days, as three North American pharmaceutical companies vie for the rights to its macular degeneration treatment.